HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia.

Abstract
This study examined the therapeutic and prophylactic potential of bacteriophages in a mouse model of Klebsiella pneumoniae lobar pneumonia. Phages were administered intraperitoneally. Liposome-entrapped phages (LP) were effective in treating infection, even when therapy was delayed by 3 days after the induction of pneumonia. In contrast, nonliposomal phages provided protection when administered 24 hours after infection. Administration of nonliposomal phages 6 hours prior to intranasal bacterial challenge resulted in complete protection, compared with LP, which was effective even when administered 48 hours prior to infection. Increased reduction and a greater increment in the levels of proinflammatory and antiinflammatory cytokines, respectively, in homogenates of lung from LP-treated mice were suggestive of increased efficacy of LP in the treatment of pneumonia. This is the first study to assess liposomes as a delivery vehicle for phage, and the results confirm the superiority of LP for both therapeutic and prophylactic applications.
AuthorsSaloni Singla, Kusum Harjai, Om Prakash Katare, Sanjay Chhibber
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 212 Issue 2 Pg. 325-34 (Jul 15 2015) ISSN: 1537-6613 [Electronic] United States
PMID25605867 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: [email protected].
Chemical References
  • Inflammation Mediators
  • Liposomes
Topics
  • Animals
  • Bacteriophages (physiology)
  • Female
  • Inflammation Mediators (metabolism)
  • Klebsiella Infections (immunology, microbiology, therapy)
  • Klebsiella pneumoniae (virology)
  • Liposomes
  • Lung (immunology, metabolism, microbiology)
  • Mice, Inbred BALB C
  • Nanostructures (administration & dosage)
  • Pneumonia, Bacterial (immunology, microbiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: